CIK 0001768446 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Climb Bio, Inc.
Sign in to watch- Ticker
- CLYM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832273741
- Phone
- 1-866-857-2596
- Business address
- 20 WILLIAM STREET, SUITE G50, WELLESLEY HILLS, MA
- Former names
- Eliem Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,366,820
- in 1 filing, $1.4M under 10b5-1 plans
Net −$1,366,820. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-28 | RA CAPITAL MANAGEMENT, L.P. Director | Option exercise | +10,000 | $3.46 | $35K | 10,000 |
| 2026-09-28 | RA CAPITAL MANAGEMENT, L.P. Director | Option exercise | +10,000 | $3.00 | $30K | 20,000 |
| 2026-09-28 | RA CAPITAL MANAGEMENT, L.P. Director | Option exercise | +10,000 | $7.89 | $79K | 30,000 |
| 2026-09-28 | RA CAPITAL MANAGEMENT, L.P. Director | Option exercise | +40,000 | $1.29 | $52K | 70,000 |
| 2026-09-28 | RA CAPITAL MANAGEMENT, L.P. Director | Option exercise · Stock Option (Right to Buy) | −10,000 | 0 | ||
| 2026-09-28 | RA CAPITAL MANAGEMENT, L.P. Director | Option exercise · Stock Option (Right to Buy) | −10,000 | 0 | ||
| 2026-09-28 | RA CAPITAL MANAGEMENT, L.P. Director | Option exercise · Stock Option (Right to Buy) | −10,000 | 0 | ||
| 2026-09-28 | RA CAPITAL MANAGEMENT, L.P. Director | Option exercise · Stock Option (Right to Buy) | −40,000 | 0 | ||
| 2026-09-15 | Thomas Stephen Basil Director | Sale 10b5-1 | −100,000 | $13.67 | $1.4M | 467,969 |
| 2026-06-29 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Stock Option (Right to Buy) | +70,284 | 70,284 | ||
| 2026-06-29 | Celebi Breanna Maurine Director | Grant or award · Stock Option (Right to Buy) | +70,284 | 70,284 | ||
| 2026-06-29 | Brennan Aoife President and CEO | Sale 10b5-1 | −30,902 | $13.17 | $407K | 87,731 |
| 2026-06-27 | Brennan Aoife President and CEO | Option exercise 10b5-1 | +68,750 | 118,633 | ||
| 2026-06-27 | Brennan Aoife President and CEO | Option exercise · Restricted Stock Units 10b5-1 | −68,750 | 137,500 | ||
| 2026-06-05 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2026-06-05 | Levin Andrew David Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2026-06-05 | Drapkin Kimberlee C Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2026-06-05 | WILLIAMS DOUGLAS E Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2026-06-05 | Cumbo Alexander Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2026-06-05 | Thomas Stephen Basil Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 |
Page 1 of 9 · 166 trades